Research Directory

Oncology Review: New drugs for myeloma, breast cancer reached the market in 2023

Read more

ESMO: New drug combinations show promise for cancer

Read more

Drugs for lung cancers and leukaemia break new ground

Read more

Novel oncology drugs approved in a year of change

Read more

Progressive increase in oncology drug approvals

Read more

Checkpoint inhibitors are focus at ESMO

Read more